Home LiteratureArticle Details
PMID: 17170761 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Mdm2 targets the p53 transcription cofactor JMY for degradation.

EMBO reports ·Vol. 8 ·No. 1 ·2007-01-00 ·Pages 84-90

Coutts AS, Boulahbel H, Graham A, La Thangue NB

Abstract

We define here a new mechanism through which Mdm2 (mouse double minute 2) regulates p53 activity, by targeting the p53 transcription cofactor JMY. DNA damage causes an increase in JMY protein, and, in a similar manner, small molecule inhibitors of Mdm2 activity induce JMY in unperturbed cells. At a mechanistic level, Mdm2 regulation of JMY requires the Mdm2 RING (really interesting new gene) finger, which promotes the ubiquitin-dependent degradation of JMY. However, regulation of JMY occurs independently of the p53-binding domain in Mdm2 and p53 activity. These results define a new functional relationship between the p53 cofactor JMY and Mdm2, and indicate that transcription cofactors that facilitate p53 activity are important targets for Mdm2 in suppressing the p53 response.

MeSH Terms
Animals Carrier Proteins/analysis,genetics,metabolism Cell Cycle Proteins Cells, Cultured DNA Damage Humans Mice Nuclear Proteins/analysis,metabolism Trans-Activators/analysis,metabolism Transcription Factors/metabolism Tumor Suppressor Protein p53/genetics,metabolism Ubiquitin/metabolism
Chemicals
Carrier Proteins Cell Cycle Proteins Jmy protein, mouse Mtbp protein, mouse Nuclear Proteins Trans-Activators Transcription Factors Tumor Suppressor Protein p53 Ubiquitin
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Coutts Amanda S
Laboratory of Cancer Biology, Division of Medical Sciences, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK.
Boulahbel Houda
Graham Anne
La Thangue Nicholas B
References (26)
26 references, click to expand
  1. Regulation of p53 stability by Mdm2.
    Nature. 1997 May 15;387(6630):299-303 PMID: 9153396
  2. p300/MDM2 complexes participate in MDM2-mediated p53 degradation.
    Mol Cell. 1998 Oct;2(4):405-15 PMID: 9809062
  3. Functions of the MDM2 oncoprotein.
    Cell Mol Life Sci. 1999 Jan;55(1):96-107 PMID: 10065155
  4. Analysis of the degradation function of Mdm2.
    Cell Growth Differ. 1999 Feb;10(2):87-92 PMID: 10074902
  5. A novel cofactor for p300 that regulates the p53 response.
    Mol Cell. 1999 Sep;4(3):365-76 PMID: 10518217
  6. The p53 response: emerging levels of co-factor complexity.
    Biochem Biophys Res Commun. 2005 Jun 10;331(3):778-85 PMID: 15865933
  7. E3 ubiquitin ligases.
    Essays Biochem. 2005;41:15-30 PMID: 16250895
  8. Polyubiquitination of p53 by a ubiquitin ligase activity of p300.
    Science. 2003 Apr 11;300(5617):342-4 PMID: 12690203
  9. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.
    Science. 2004 Feb 6;303(5659):844-8 PMID: 14704432
  10. A new effector pathway links ATM kinase with the DNA damage response.
    Nat Cell Biol. 2004 Oct;6(10):968-76 PMID: 15448695
  11. mdm2 expression is induced by wild type p53 activity.
    EMBO J. 1993 Feb;12(2):461-8 PMID: 8440237
  12. Database of p53 gene somatic mutations in human tumors and cell lines.
    Nucleic Acids Res. 1994 Sep;22(17):3551-5 PMID: 7937055
  13. mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein.
    Mol Cell Biol. 1996 May;16(5):2445-52 PMID: 8628312
  14. p53, the cellular gatekeeper for growth and division.
    Cell. 1997 Feb 7;88(3):323-31 PMID: 9039259
  15. Mdm2 promotes the rapid degradation of p53.
    Nature. 1997 May 15;387(6630):296-9 PMID: 9153395
  16. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53.
    J Biol Chem. 2000 Mar 24;275(12):8945-51 PMID: 10722742
  17. Stress signals utilize multiple pathways to stabilize p53.
    Mol Cell Biol. 2000 May;20(9):3224-33 PMID: 10757806
  18. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53.
    Nat Cell Biol. 2000 Sep;2(9):563-8 PMID: 10980695
  19. The MDM2 RING-finger domain is required to promote p53 nuclear export.
    Nat Cell Biol. 2000 Sep;2(9):569-73 PMID: 10980696
  20. Mdm2 mutant defective in binding p300 promotes ubiquitination but not degradation of p53: evidence for the role of p300 in integrating ubiquitination and proteolysis.
    J Biol Chem. 2001 Aug 10;276(32):29695-701 PMID: 11340074
  21. A TPR motif cofactor contributes to p300 activity in the p53 response.
    Mol Cell. 2001 Jul;8(1):71-84 PMID: 11511361
  22. p300/CBP proteins: HATs for transcriptional bridges and scaffolds.
    J Cell Sci. 2001 Jul;114(Pt 13):2363-73 PMID: 11559745
  23. C-terminal ubiquitination of p53 contributes to nuclear export.
    Mol Cell Biol. 2001 Dec;21(24):8521-32 PMID: 11713287
  24. p53-Mdm2--the affair that never ends.
    Carcinogenesis. 2002 Apr;23(4):541-7 PMID: 11960904
  25. Live or let die: the cell's response to p53.
    Nat Rev Cancer. 2002 Aug;2(8):594-604 PMID: 12154352
  26. Differentiation of Hdm2-mediated p53 ubiquitination and Hdm2 autoubiquitination activity by small molecular weight inhibitors.
    Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14734-9 PMID: 12407176
Article Info
Journal
EMBO reports
Abbr.
EMBO Rep
ISSN
1469-221X
Published
2007-01-00
Epub
2006-00-15
Pages
84-90
Language
English
Region
England
NLM ID
100963049
PMCID
PMC1796743
Subset
IM
Grants
Cancer Research UK · 13058 · United Kingdom
Medical Research Council · G0500905 · United Kingdom
Medical Research Council · G9400953 · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com